5.6.3 Clinical study details 86
5.7 Ipilimumab (Bristol-Myers Squibb) 86
5.7.1 Overview 86
5.7.2 Mechanism of Action 86
5.7.3 Clinical Study Details 86
5.8 BiovaxID (Accentia Biopharmaceuticals, Inc.) 87
5.8.1 Overview 87
5.8.2 Mechanism of Action 87
5.8.3 Clinical Study Details 87
6 Personalized Medicine Market: Research Trends in Personalized Medicine 88
7 Personalized Medicine Market: Competitive Landscape 89
7.1 Competitive Profiling 89
7.2 Clarient, Inc. 89
7.2.1 Business Description 89
7.2.2 Pipeline 90
7.2.3 Major Products 90
7.2.4 Partnership and Merger and Acquisition (M&A) Deals 91
7.3 Qiagen N.V. 92
7.3.1 Business Description 92
7.3.2 Pipeline 92
7.3.3 Major Products 92
7.3.4 Partnership and M&A Deals 94
7.4 Laboratory Corporation of America Holdings 96
7.4.1 Business Description 96
7.4.2 Pipeline 96
7.4.3 Major Products 96
7.4.4 Partnership and M&A Deals 97
7.5 bioMerieux S.A. 99
7.5.1 Business Description 99
7.5.2 Pipeline 99
7.5.3 Major Products 99
7.5.4 Partnership and M&A Deals 100
7.5.5 Partnership and M&A Deals 102
7.6 Pfizer 102
7.6.1 Business Overview 102
7.6.2 Partnership and M&A Deals 103
7.7 Eli Lily and Company 104
7.7.1 Business Overview 104
7.7.2 Partnership and M&A deals 105
7.8 Novartis 106
7.8.1 Business Overview 106
7.8.2 Partnership and M&A Deals 107
7.9 F. Hoffman La Roche 108
7.9.1 Business Overview 108
7.9.2 Diagnostics 108
7.9.3 Pharmaceuticals 109
7.9.4 Partnership and M&A Deals 110
7.10 Bristol-Myers Squibb 111
7.10.1 Business Overview 111
7.10.2 Partnership and M&A deals 112
7.11 Merck KGaA 113
7.11.1 Business Overvie
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |